Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments on Tuesday, May 15, 2018
May 11, 2018 09:10 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., May 11, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
May 10, 2018 09:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) Test
May 08, 2018 06:30 ET
|
Exosome Diagnostics
Waltham, MA, May 08, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has expanded its urology salesforce within the United States after a successful first quarter commercial launch of ExoDx...
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 2, 2018
April 25, 2018 16:15 ET
|
Rennova Health, Inc.
WEST PALM BEACH, Fla, April 25, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading...
RENNOVA HEALTH ANNOUNCES 2017 FINANCIAL RESULTS
April 24, 2018 17:50 ET
|
Rennova Health, Inc.
WEST PALM BEACH, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading...
Precipio Completes a $3M Convertible Debt Facility
April 23, 2018 07:37 ET
|
Precipio, Inc.
Management focuses on growth opportunities NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that it entered into a...
United States Non-Invasive Prenatal Testing (NIPT) Market to Top USD 2.5 Billion by 2023
April 19, 2018 09:00 ET
|
Report Sellers
Raipur, April 19, 2018 (GLOBE NEWSWIRE) -- Report Sellers has added a new market research report “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By...
Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
April 18, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell
April 18, 2018 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it is in active licensing discussions with several potential partners...
VisionGate, Inc. Appoints Randal Buness as Chief Financial Officer
April 17, 2018 18:34 ET
|
VisionGate, Inc.
SEATTLE, WA, April 17, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce the appointment of Randal Buness, CPA, MBA as...